☆ 4.6 Review

Malaria chemoprophylaxis: Strategies for risk groups

CLINICAL MICROBIOLOGY REVIEWS (2008)

Journal

CLINICAL MICROBIOLOGY REVIEWS

Volume 21, Issue 3, Pages 466-472

Publisher

AMER SOC MICROBIOLOGY

DOI: 10.1128/CMR.00059-07

Keywords

-

Categories

Microbiology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Editorial Material Public, Environmental & Occupational Health

Malaria in sub-Saharan Africa-a continuing risk for international travellers

Ralph Huits, Davidson H. Hamer

Summary: International travel volumes are recovering after the COVID-19 pandemic, but travelers to sub-Saharan Africa still face a high risk of malaria. Health practitioners are needed to prescribe and facilitate access to affordable antimalarial chemoprophylaxis and to provide high-quality diagnostic services and therapeutic care for case management.

JOURNAL OF TRAVEL MEDICINE (2022)

Add to Collection

Editorial Material Immunology

Return to Travel in the Coronavirus Disease 2019 Pandemic Recovery Period and Implications for Imported Malaria: Reinforcing Prevention, Early Diagnosis, and Appropriate Treatment of Malaria

Jonathan S. Schultz, Kimberly E. Mace, Kathrine R. Tan

Summary: The increase in international travel during the COVID-19 pandemic recovery period is expected to lead to an increase in imported malaria cases in the US. Prevention, timely diagnosis, and appropriate treatment are crucial in minimizing imported malaria morbidity and mortality. Intravenous artesunate (IVAS) is now available for severe malaria treatment in the US. Hospitals and pharmacists should have a malaria treatment plan that includes stocking artemether-lumefantrine for uncomplicated malaria and ensuring access to IVAS for severe cases.

CLINICAL INFECTIOUS DISEASES (2023)

Add to Collection

Review Public, Environmental & Occupational Health

Prevalence, anti-malarial chemoprophylaxis and causes of deaths for severe imported malaria: A systematic review and meta-analysis

Aongart Mahittikorn, Wanida Mala, Polrat Wilairatana, Sukhontha Siri, Frederick Ramirez Masangkay, Kwuntida Uthaisar Kotepui, Manas Kotepui

Summary: This study conducted a systematic review and meta-analysis to characterize the prevalence, anti-malarial chemoprophylaxis, and causes of death for severe imported malaria. The results showed that the prevalence of severe imported malaria and deaths attributable to severe imported malaria was significant, while the prevalence of adequate anti-malarial chemoprophylaxis was low among patients with severe imported malaria. Multi-organ failure was identified as the most common cause of death. These findings emphasize the importance of education and preventative measures for individuals visiting malaria-endemic areas to minimize the risk of severe disease or death.

TRAVEL MEDICINE AND INFECTIOUS DISEASE (2022)

Add to Collection

Article Public, Environmental & Occupational Health

On the potential for discontinuing atovaquone-proguanil (AP) ad-hoc post-exposure and other abbreviated AP-regimens: Pharmacology, pharmacokinetics and perspectives

Jenny L. Schnyder, Hanna K. de Jong, Emmanuel B. Bache, Reinier M. van Hest, Patricia Schlagenhauf, Steffen Borrmann, Thomas Hanscheid, Martin P. Grobusch

Summary: According to current guidelines, atovaquone-proguanil (AP) malaria chemoprophylaxis should be taken once daily starting one day before travel and continued for seven days post-exposure. However, drug-sparing regimens, including discontinuing AP after leaving malaria-endemic areas are cost-saving and probably more attractive to travelers, and may enhance adherence. Field trials require large numbers of travelers and safely-designed controlled human malaria infection trials could establish an effective AP abbreviated regimen which we propose as the optimal trial design to test this concept.

TRAVEL MEDICINE AND INFECTIOUS DISEASE (2023)

Add to Collection

Article Immunology

Impact of Chemoprophylaxis on Plasmodium vivax and Plasmodium ovale Infection Among Civilian Travelers: A Nested Case-Control Study With a Counterfactual Approach on 862 Patients

Maelle Le Goff, Eric Kendjo, Marc Thellier, Renaud Piarroux, Pierre Yves Boelle, Stephane Jaureguiberry

Summary: This study analyzed the impact of chemoprophylaxis on the outcomes of Plasmodium vivax and Plasmodium ovale infections in civilian travelers. It found that travelers using blood-stage drugs were at a higher risk of delayed-onset illness. This calls for new chemoprophylaxis acting on liver stages.

CLINICAL INFECTIOUS DISEASES (2023)

Add to Collection

Article Immunology

Safety, Pharmacokinetics, and Causal Prophylactic Efficacy of KAF156 in a Plasmodium falciparum Human Infection Study

James G. Kublin, Sean C. Murphy, Janine Maenza, Annette M. Seilie, Jay Prakash Jain, David Berger, Danielle Spera, Rong Zhao, Rachel L. Soon, Julie L. Czartoski, Meredith A. Potochnic, Elizabeth Duke, Ming Chang, Ashley Vaughan, Stefan H. Kappe, F. Joel Leong, Peter Pertel, William T. Prince

Summary: KAF156, a novel antimalarial drug with high protective efficacy, was found to be safe and well tolerated in a controlled human malaria infection model. Different doses of KAF156 showed varying levels of protection against malaria infection, with higher doses providing greater protection.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Review Infectious Diseases

Evidence of malarial chemoprophylaxis among travellers who died from malaria: a systematic review and meta-analysis

Manas Kotepui, Kwuntida Uthaisar Kotepui, Frederick Ramirez Masangkay, Polrat Wilairatana

Summary: Among studies on chemoprophylaxis, around 30% of malaria death cases had taken prophylaxis, with only 5% adhering fully or adequately to the recommended regimen. Nonetheless, there was no significant difference in the odds of chemoprophylaxis between malaria death cases and survivors.

MALARIA JOURNAL (2023)

Add to Collection

Article Public, Environmental & Occupational Health

Discontinuing atovaquone/proguanil prophylaxis ad-hoc post-exposure and during-travel dose-sparing prophylactic regimens against P. falciparum malaria: An update with pointers for future research

Jenny L. Schnyder, Hanna K. de Jong, Patricia Schlagenhauf, Steffen Borrmann, Thomas Hanscheid, Martin P. Grobusch

Summary: This article reviews the latest research on abbreviated Atovaquone/Proguanil (AP) regimens during travel. Although previous studies have shown that discontinuing the treatment upon return may be effective, the available data is insufficient to modify current guidelines.

TRAVEL MEDICINE AND INFECTIOUS DISEASE (2022)

Add to Collection

Article Infectious Diseases

Survey and Analysis of Chemoprophylaxis Policies for Domestic Travel in Malaria-Endemic Countries

John Kevin Baird, Marian Warsame, Judith Recht

Summary: There is a lack of unified policies and guidelines for chemoprophylaxis of malaria among domestic travelers in malaria-endemic countries, mainly due to the incomplete protection offered by commonly used suppressive prophylaxis drugs and impractical dosing.

TROPICAL MEDICINE AND INFECTIOUS DISEASE (2022)

Add to Collection

Article Microbiology

Suspected Severe Malaria in a Sudanese Patient Affected by Sickle Cell Disease Who Was Treated with Hydroxyurea

Giulia Chiopris, Stefano Maccario, Tawaddud Hassan Eisa Artaiga, Abdalrhman Ibrahim Mohamed, Manuela Valenti, Susanna Esposito

Summary: Sickle cell disease is the most common genetic disease in sub-Saharan Africa, with symptoms usually appearing in early childhood. Patients with SCD are at risk of malaria in endemic countries, and guidelines recommend antimalarial chemoprophylaxis. Hydroxyurea is considered a safe and effective treatment for SCD, although its impact on malaria incidence and severity still needs further demonstration.

PATHOGENS (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Hair concentrations of anti-malarials in returned travellers-the HAIR study: Proof of principle analysis

Regula Steiner, Anne Kaulich, Daniel Miller, Patricia Schlagenhauf

Summary: This study aimed to establish a methodology to monitor adherence to antimalarial drugs using hair analysis. The results showed that atovaquone, proguanil, and mefloquine can be detected and quantified in hair samples using liquid chromatography-tandem mass spectrometry. The concentration of the drugs in hair correlated with the time interval since finishing the chemoprophylaxis regimen.

TRAVEL MEDICINE AND INFECTIOUS DISEASE (2023)

Add to Collection

Article Infectious Diseases

Should anti-malarial chemoprophylaxis be reimbursed in France? A cost-effectiveness analysis of different reimbursement strategies

C. Fiorina, J-M. Josselin, M. Trepart-Normand, P. Tattevin, E. Bajeux

Summary: This study evaluates the cost and effectiveness of reimbursing drugs for malaria chemoprophylaxis in France. The findings suggest that reimbursement could lead to a decrease in malaria cases. Targeting high-risk individuals or specific groups for reimbursement may be more efficient.

INFECTIOUS DISEASES NOW (2022)

Add to Collection

Article Ergonomics

Active traffic management strategies for expressways based on crash risk prediction of moving vehicle groups

Wanjing Ma, Ziliang He, Ling Wang, Mohamed Abdel-Aty, Chunhui Yu

Summary: Active traffic management (ATM) strategies such as variable speed limits (VSLs), ramp metering (RM), and coordinated VSL and RM (VSL-RM) are effective in reducing crash risk and improving expressway safety. Testing on a micro-simulation network showed that ATM strategies improved expressway safety benefits by 2.84-15.92%.

ACCIDENT ANALYSIS AND PREVENTION (2021)

Add to Collection

Review Immunology

Plasmodium infection and drug cure for malaria vaccine development

Reshma J. Nevagi, Michael F. Good, Danielle I. Stanisic

Summary: Despite years of research, an efficacious malaria vaccine has not been developed yet. Whole parasite-based vaccine approaches are being evaluated to induce immune responses against multiple parasite antigens. Deliberate Plasmodium IDC involves administering live parasites with an anti-malarial drug to control infection and induce protective immune responses.

EXPERT REVIEW OF VACCINES (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Introducing field digital data collection systems into seasonal malaria chemoprevention campaigns: opportunities for robust evidence development and national e-health strategies

Kanda Balla, Kezia Malm, Ousman Njie, Aurore Hounto Ogouyemi, Perpetua Uhomoibhi, Abena Poku-Awuku, Andre-Marie Tchouatieu, Rock Aikpon, Alieu Bah, Olimatou Kolley, Nnenna Ogbulafor, Samuel Oppong, Kofi Adomako, William Houndjo, Huja Jah, Jaya Banerji, Jamilu Nikau, Cyriaque Affoukou, Elijah Egwu, Camille Houtohossou, Suzanne Van Hulle

Summary: Using digital data collection tools in seasonal malaria chemoprevention campaigns can overcome data quality and operational challenges, making data more accessible. Scaling up digital tools and integrating them with routine health management systems can generate robust evidence for malaria policy development and programming.

BMJ GLOBAL HEALTH (2022)

Add to Collection

Article Public, Environmental & Occupational Health

Use of repellents by travellers: A randomised, quantitative analysis of applied dosage and an evaluation of knowledge, Attitudes and Practices (KAP)

Thomas Hasler, Jan Fehr, Ulrike Held, Patricia Schlagenhauf

TRAVEL MEDICINE AND INFECTIOUS DISEASE (2019)

Add to Collection

Letter Infectious Diseases

Where do Eritrean migrants get infected with malaria? The importance of considering the migration route

Philippe Gautret, Martin P. Grobusch, Patricia Schlagenhauf

EUROSURVEILLANCE (2019)

Add to Collection

Editorial Material Public, Environmental & Occupational Health

The art of travel medicine and infectious disease

Patricia Schlagenhauf

TRAVEL MEDICINE AND INFECTIOUS DISEASE (2019)

Add to Collection

Editorial Material Public, Environmental & Occupational Health

The march of measles - Can travel medicine halt the pace?

Dipti Patel, Hilary Simons, Patricia Schlagenhauf

TRAVEL MEDICINE AND INFECTIOUS DISEASE (2019)

Add to Collection

Review Public, Environmental & Occupational Health

Self-diagnosis and self-treatment of Plasmodium spp. infection by travellers (1989-2019): A systematic review and meta-analysis

Khyra S. Utzinger, Ulrike Held, Thomas Hanscheid, Nelja Gultekin, Jan Fehr, Martin P. Grobusch, Patricia Schlagenhauf

TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)

Add to Collection

Review Public, Environmental & Occupational Health

Immunogenicity and safety of the tick-borne encephalitis vaccination (2009-2019): A systematic review

John Ethan Rampa, Helena Hervius Askling, Phung Lang, Kyra Denise Zens, Nejla Gultekin, Zeno Stanga, Patricia Schlagenhauf

TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)

Add to Collection

Review Public, Environmental & Occupational Health

Efficacy and safety of tafenoquine for malaria chemoprophylaxis (1998-2020): A systematic review and meta-analysis

Julian D. Maier, Sandra Siegfried, Nejla Gultekin, Zeno Stanga, J. Kevin Baird, Martin P. Grobusch, Patricia Schlagenhauf

Summary: The study evaluated the safety and efficacy of tafenoquine as a malaria chemoprophylaxis, finding that 200 mg weekly tafenoquine is effective in preventing Plasmodium infection with good tolerability. However, some users may experience gastrointestinal adverse events and short-term eye issues. Further research is needed to explore tafenoquine use in diverse traveler populations.

TRAVEL MEDICINE AND INFECTIOUS DISEASE (2021)

Add to Collection

Review Public, Environmental & Occupational Health

Air travel and COVID-19 prevention in the pandemic and peri-pandemic period: A narrative review

Michel Bielecki, Dipti Patel, Jochen Hinkelbein, Matthieu Komorowski, John Kester, Shahul Ebrahim, Alfonso J. Rodriguez-Morales, Ziad A. Memish, Patricia Schlagenhauf

Summary: Air travel during the COVID-19 pandemic faces challenges for travellers, airlines, and authorities, with reduced flights, effective preventive measures like hygiene, mask use, and social distancing, but unreliable temperature screening. The risk of in-flight transmission is low but caution is necessary, with ongoing research needed for evidence-based preventive measures and safety assessments.

TRAVEL MEDICINE AND INFECTIOUS DISEASE (2021)

Add to Collection

Review Public, Environmental & Occupational Health

Mobile apps for travel medicine and ethical considerations: A systematic review

Agata Ferretti, Nadja Hedrich, Thibault Lovey, Effy Vayena, Patricia Schlagenhauf

Summary: This study highlights the lack of discussion around ethical issues in mobile apps for travel medicine, emphasizing the need for researchers and developers to better integrate ethical reflection at each step. More effective oversight mechanisms and clearer ethical guidance are necessary to guide stakeholders in this endeavor.

TRAVEL MEDICINE AND INFECTIOUS DISEASE (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Imported malaria in Switzerland, (1990-2019): A retrospective analysis

Bodo Giannone, Nadja Hedrich, Patricia Schlagenhauf

Summary: This study investigated the epidemiology and characteristics of imported malaria in Switzerland between 1990 and 2019. The results showed that the main source of infection was West Africa, followed by Central Africa and East Africa. The profile of malaria in migrants in Switzerland has changed over time, reflecting changes in migrant flows. The risk of malaria in travelers significantly decreased during the study period.

TRAVEL MEDICINE AND INFECTIOUS DISEASE (2022)

Add to Collection

Editorial Material Public, Environmental & Occupational Health

Tafenoquine for malaria chemoprophylaxis - Status quo 2022

Patricia Schlagenhauf, Julian D. Maier, Martin P. Grobusch

TRAVEL MEDICINE AND INFECTIOUS DISEASE (2022)

Add to Collection

Editorial Material Infectious Diseases

Outbreaks of iatrogenic botulism in Europe: Combating off-label medical use of Botulinum Neurotoxin (BoNT) in bariatric procedures

Nityanand Jain, Edouard Lansiaux, Umut Yucel, Swantje Huenermund, Stella Goeschl, Patricia Schlagenhauf

NEW MICROBES AND NEW INFECTIONS (2023)

Add to Collection

Article Public, Environmental & Occupational Health

Hair concentrations of anti-malarials in returned travellers-the HAIR study: Proof of principle analysis

Regula Steiner, Anne Kaulich, Daniel Miller, Patricia Schlagenhauf

Summary: This study aimed to establish a methodology to monitor adherence to antimalarial drugs using hair analysis. The results showed that atovaquone, proguanil, and mefloquine can be detected and quantified in hair samples using liquid chromatography-tandem mass spectrometry. The concentration of the drugs in hair correlated with the time interval since finishing the chemoprophylaxis regimen.

TRAVEL MEDICINE AND INFECTIOUS DISEASE (2023)

Add to Collection

Article Infectious Diseases

Illness tracking in SARS-CoV-2 tested persons using a smartphone app: a non-interventional, prospective, cohort study

T. Lovey, M. Bielecki, N. Gultekin, A. Stettbacher, F. Muggli, Z. Stanga, A. Farnham, J. Deuel, P. Schlagenhauf

Summary: This study aimed to evaluate the spectrum, duration, and impact of symptoms reported by SARS-CoV-2 infected individuals and compare them to those who tested negative. The results showed that positive individuals reported more symptoms typical of COVID-19, and some of these symptoms had a significant impact on daily activities. The study also found that remote monitoring of symptoms in infected individuals using a smartphone app was feasible.

NEW MICROBES AND NEW INFECTIONS (2022)

Add to Collection

Review Public, Environmental & Occupational Health

Reprint of: Air travel and COVID-19 prevention in the pandemic and peri-pandemic period: A narrative review

Michel Bielecki, Dipti Patel, Jochen Hinkelbein, Matthieu Komorowski, John Kester, Shahul Ebrahim, Alfonso J. Rodriguez-Morales, Ziad A. Memish, Patricia Schlagenhauf

TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.